Monday, November 24, 2014

Deals

Logos Biosystems to License “Clarity™” Technology from Stanford University

November 23, 2014 · Leave a Comment 

  Anyang, South Korea, November 21, 2014 –(PR.com)– Innovative technology provides big potential for breakthroughs in brain mapping research. Licensing agreement is the first step for Logos Biosystems to generate the world’s first commercial instrument for the Clarity technology. Logos Biosystems, a leading developer of various cellular imaging instruments for life science research, announced that it has entered into an agreement with Stanford University in order to access to the intellectual properties for the Clarity™ technology. Clarity™, created by Professor Karl Deisseroth... [Read the full story]

Deal News

Logos Biosystems to License “Clarity™” Technology from Stanford University

November 23, 2014 · Leave a Comment 

  Anyang, South Korea, November 21, 2014 –(PR.com)– Innovative technology provides big potential for breakthroughs in brain mapping research. Licensing agreement is the first step for Logos Biosystems to generate the world’s first commercial instrument for the Clarity technology. Logos Biosystems, a leading developer of various cellular imaging instruments for life science research, announced that it has entered into an agreement with Stanford University in order to access to the intellectual properties for the Clarity™ technology. Clarity™, created by Professor Karl Deisseroth... [Read the full story]

Legal

UF, BP settle long-running dispute, though impact to university remains unclear

August 9, 2014 · Leave a Comment 

  A partnership with British Petroleum that should have produced a stream of royalty revenues for the University of Florida for years has evaporated with the stroke of a pen, settling a two-year court battle over $30 million in disputed fees and royalties. The two sides in the intellectual property suit that BP brought against UF quietly reached a settlement agreement over the disputed licensing fees and royalties for a process invented by UF researcher Lonnie Ingram that converts wood pulp into ethanol. A federal judge dismissed the suit in December, reserving the right to bring both sides... [Read the full story]

Bio

Logos Biosystems to License “Clarity™” Technology from Stanford University

November 23, 2014 · Leave a Comment 

  Anyang, South Korea, November 21, 2014 –(PR.com)– Innovative technology provides big potential for breakthroughs in brain mapping research. Licensing agreement is the first step for Logos Biosystems to generate the world’s first commercial instrument for the Clarity technology. Logos Biosystems, a leading developer of various cellular imaging instruments for life science research, announced that it has entered into an agreement with Stanford University in order to access to the intellectual properties for the Clarity™ technology. Clarity™, created by Professor Karl Deisseroth... [Read the full story]

University Tech Transfer

The Texas A&M University System and XOMA License Innovative Manufacturing Technology

October 7, 2014 · Leave a Comment 

  COLLEGE STATION, Texas and BERKELEY, Calif., Oct. 6, 2014 (GLOBE NEWSWIRE) — The Texas A&M University System and XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced that the Texas A&M University System agreed to a non-exclusive license for XOMA’s innovative design of a manufacturing facility. The patented technology relates to a flexible arrangement of mobile clean rooms (MCRs) within the manufacturing facility with each MCR providing a portable, self-contained environment that allows for drug development.... [Read the full story]

People

Boulder’s Innovation Center of the Rockies signs commercialization agreement with University of Wyoming

October 11, 2013 · Leave a Comment 

  The Innovation Center of the Rockies, a Boulder-based organization created to help research institutions commercialize technology, has entered into an agreement with the University of Wyoming, officials announced Tuesday. Financial terms of the agreement were not disclosed. The University of Wyoming is the first commercialization partner outside the state of Colorado for the nonprofit Innovation Center of the Rockies, which has inked similar deals with the University of Colorado, Colorado School of Mines, Colorado State University and the University of Denver. “I think that we’ve... [Read the full story]

Deals

Logos Biosystems to License “Clarity™” Technology from Stanford University

  Anyang, South Korea, November 21, 2014 –(PR.com)– Innovative technology provides big potential for breakthroughs in brain mapping research. Licensing agreement is the first step for Logos Biosystems to generate the world’s first commercial instrument for the Clarity technology. Logos Biosystems, a leading developer of various cellular... Read more of this article


Naturally Splendid USA Secures Agreement to License Hemp and Cannabinoid Extraction and Formulation

  November 20 2014 – Vancouver, BC – Naturally Splendid Enterprises (the “Company”) (NSP – TSX Venture) (NSPDF – OTCQB) (50N – Frankfurt) is pleased to announce Naturally Splendid USA Ltd., its wholly owned subsidiary, (“Naturally Splendid USA”) has entered into a Novation Agreement with  Full Spectrum Laboratories Limited (“FSL”),... Read more of this article


3SBio Signs Exclusive Patent License Agreement with PharmAbcine

  SHENYANG, China and DAEJEON, Korea, Nov. 18, 2014 /PRNewswire/ — 3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with PharmAbcine, Inc. for the development, manufacturing and marketing... Read more of this article


Acacia Subsidiary Enters into Settlement and Patent License Agreement with NEC Corporation

  Acacia Research Corporation (NASDAQ:ACTG) announced today that its Cellular Communications Equipment LLC subsidiary has entered into a settlement and patent license agreement with NEC Corporation and its subsidiaries. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas.  Read More →


Acelity Acquires Worldwide License for Fat Grafting Technology to Strengthen Plastic Surgery Portfolio

  Acelity today announced that it has acquired exclusive worldwide rights from The GID Group, Inc. for the REVOLVE™ System, a fat processing technology used in both reconstructive and cosmetic procedures to facilitate high-volume, autologous fat grafting. LifeCell Corporation, an Acelity Company, has held exclusive rights to distribute the REVOLVE™... Read more of this article


Ikaria and Lee’s Pharmaceutical Announce Strategic Partnership

  HAMPTON, N.J. and HONG KONG, Nov. 19, 2014 /PRNewswire/ – Ikaria, Inc. (through its INO Therapeutics subsidiary) and Lee’s Pharmaceutical (HK) Limited today announced the signing of a strategic partnership for the registration and commercialization of Ikaria’s INOMAX® Total Care package throughout the People’s Republic... Read more of this article


Nokia licenses brand and IP

  Nokia (NYSE:NOK) is jumping back into the consumer device market by licensing its brand to Foxconn to create a tablet called the N1 running Google’s (NASDAQ: GOOG) Android platform. The device, which will be manufactured, distributed and sold by Foxconn, is Nokia’s first step back into the devices market after it sold its handset... Read more of this article


MiNA Completes Exclusive License Agreement with University of California San Francisco

  MiNA Therapeutics, the pioneer in RNA activation therapeutics, announced today that it has completed an exclusive license agreement with The Regents of the University of California relating to intellectual property rights developed by the Li lab at UC San Francisco (UCSF). The exclusive license complements MiNA’s fundamental intellectual property... Read more of this article


Pfizer, Merck KGaA Partner

  Pfizer Inc. (NYSE:PFE) announced today that it has entered into an agreement with Merck KGaA, Darmstadt, Germany, to jointly develop and commercialize MSB0010718C, an investigational anti-PD-L1 antibody currently in development by Merck KGaA as a potential treatment for multiple types of cancer. Pfizer and Merck KGaA will explore the therapeutic... Read more of this article


Cardiome Enters Commercialization Agreement with Aspen

  Vancouver, Canada, November 17, 2014 — Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that an affiliate of the company has entered into an agreement with Pharmacare Limited, which trades as Aspen Pharmacare and is a part of the Aspen Group, to sell and distribute BRINAVESS® (vernakalant intravenous) exclusively in South... Read more of this article


More Posts From Deals

Legal

UF, BP settle long-running dispute, though impact to university remains unclear

  A partnership with British Petroleum that should have produced a stream of... 


InterDigital Announces Patent License Agreement With Samsung

  WILMINGTON, Del., June 3, 2014 (GLOBE NEWSWIRE) — InterDigital, Inc.... 


More Posts From Legal

University Tech Transfer

The Texas A&M University System and XOMA License Innovative Manufacturing Technology

  COLLEGE STATION, Texas and BERKELEY, Calif., Oct. 6, 2014 (GLOBE NEWSWIRE)... 


Meridian Bioscience and the University of Tennessee Research Foundation Enter into a License Agreement for Electrokinetic Sensor Technology

  CINCINNATI, Aug 06, 2014 (BUSINESS WIRE) — Meridian Bioscience, Inc.... 


More Posts From University Tech Transfer